(Q43143787)

14 November 2017

title

Influence of metabolic syndrome on risk stratification in hypertensive patients: differences between 2003 and 2007 ESH-ESC guidelines (English)

1 reference

14 November 2017

1 reference

Nieves Martell

1

1 reference

14 November 2017

Beatriz Alvarez-Alvarez

series ordinal

2

1 reference

14 November 2017

Arturo Fernandez-Cruz

series ordinal

3

1 reference

14 November 2017

publication date

3 March 2010

1 reference

Therapeutic advances in cardiovascular disease

14 November 2017

published in

1 reference

14 November 2017

volume

4

1 reference

14 November 2017

issue

2

1 reference

14 November 2017

page(s)

97-103

1 reference

Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Blood pressure control and physician management of hypertension in hospital hypertension units in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Deterioration of insulin sensitivity and glucose effectiveness with age and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Metabolic syndrome and target organ damage in untreated essential hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Is insulin resistance the cause of the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Metabolic syndrome and risk for heart failure in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Metabolic syndrome and the risk of stroke in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Influence of metabolic syndrome on hypertension-related target organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Prognostic value of the metabolic syndrome in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944709341304

21 January 2018

Identifiers

DOI

10.1177/1753944709341304

1 reference

14 November 2017

1 reference